Leader in research and development - Interpharma

Topic

Leader in research and development

Pharmacological and technological innovations will lead to rapid improvements in medicinal products. Digitalisation, in particular, will bring about a fundamental change in the way medicines are developed and used, enabling new approaches to be adopted in research. These will create great potential for medical progress and benefits for patients. A concerted effort by all players is needed in order to implement this potential.

Recent articles

3 questions to the new Interpharma Board members: Anne Mette Wiis Vogelsang, CVP & General Manager Novo Nordisk Switzerland

3 questions to our new board member: Dimitri Gitas General Manager Switzerland – MSD

3 questions to Daniel Weber: Member of the Interpharma Board and Country Head Switzerland Boehringer Ingelheim

Latest publications

Rare diseases

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2023

read more

Board and Executive Management

Introducing Interpharma

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more

Contact

Contact us

read more

Media

Latest information and media contacts for media representatives

read more